Skip to main content
. Author manuscript; available in PMC: 2016 Aug 24.
Published in final edited form as: J Bone Miner Res. 2015 May 27;30(9):1627–1640. doi: 10.1002/jbmr.2490

Fig. 7.

Fig. 7

Representative H&E-stained images from maxilla of all groups. (A–C) Healthy site of veh, OPG-Fc, and ZA animals. (D–F) Diseased site at 11 weeks at the end of antiresorptive treatment. (G–I) Diseased site of veh, OPG-Fc, and ZA 6 weeks after antiresorptive discontinuation. (J–L) Diseased site of veh, OPG-Fc, and ZA 10 weeks after antiresorptive discontinuation. Red arrows point to marginal gingival epithelium, turquoise arrows to alveolar crest, black arrows to areas of inflammation, blue arrows to periosteal bone deposition, yellow arrows to osteonecrotic areas, and green arrows to areas of bone exposure. Original magnification ×5.

HHS Vulnerability Disclosure